HISTOPATHOLOGICAL CORRELATION OF PLACENTA ACCRETA SPECTRUMWITH CLINICAL AND INTRAOPERATIVE FINDINGS

Main Article Content

Dr. Pavithra Dharmapuri
Dr. Vinita Nayak
Dr. Haritha Mylavarapu

Keywords

placenta accreta spectrum, placenta accreta, placenta increta, placenta percreta, histopathology, cesarean hysterectomy, placenta previa, obstetric hemorrhage

Abstract

Background: Placenta accreta spectrum (PAS) comprises abnormal placental adherence and/or invasion and is associated with major maternal morbidity, especially obstetric hemorrhage, transfusion and urinary tract injury. Antenatal imaging is central to diagnosis and operative planning, while histopathology provides tissue-based confirmation when hysterectomy or uterine resection specimens are available.
Aim: To evaluate the histopathological spectrum of PAS and correlate pathological findings with antenatal imaging, risk factors and intraoperative findings in a 100-case cohort.
Methods: One hundred women with suspected or clinically diagnosed PAS who underwent cesarean hysterectomy or uterine resection were done. Maternal age, parity, previous cesareans, placenta previa/low-lying placenta, antenatal ultrasound/MRI impression, estimated blood loss, transfusion and urologic injury were recorded. Histopathology assessed the placental implantation site and depth of villous invasion. Descriptive statistics and cross-tabulation were used.
Results: Mean maternal age was 31.9 ± 5.0 years. Previous cesarean delivery occurred in 92%, placenta previa/low-lying placenta in 78%, and both in 74%. Antenatal imaging suspected PAS in 91%. Histopathology classified 34% as accreta, 42% as increta and 24% as percreta. Median estimated blood loss was 1800 mL. Packed red-cell transfusion occurred in 63%, massive transfusion (≥4 units) in 27%, and bladder injury in 12%. Percreta had the highest frequency of major blood loss, transfusion and bladder injury.
Conclusion: PAS demonstrates clinically meaningful correlation among antenatal risk factors, imaging, intraoperative severity and histopathological depth of invasion. Standardized pathology reporting complements multidisciplinary antenatal planning and allows clinicopathological audit.



Abstract 0 | PDF Downloads 0

References

1.ACOG; Society for Maternal-Fetal Medicine. Obstetric Care Consensus No. 7: Placenta Accreta Spectrum. Obstet Gynecol. 2016;132:e259–e275.
2.Jauniaux E, Chantraine F, Silver RM, Langhoff-Roos J. FIGO consensus guidelines on placenta accreta spectrum disorders: epidemiology. Int J Gynaecol Obstet. 2015;146:265–273.
3.Jauniaux E, Bhide A. Prenatal ultrasound diagnosis and outcome of placenta accreta after cesarean delivery: systematic review and meta-analysis. Am J Obstet Gynecol. 2013;217:27–36.
4.Jauniaux E, Ayres-de-Campos D, Langhoff-Roos J, et al. FIGO consensus guidelines on placenta accreta spectrum disorders: diagnosis and screening. Int J Gynaecol Obstet. 2010;146:274–298.
5.Jauniaux E, Kingdom JC, Silver RM. A comparison of recent guidelines on diagnosis and management of placenta accreta spectrum disorders. Best Pract Res Clin Obstet Gynaecol. 2008;87:102337.
6.Silver RM. Abnormal placentation: placenta previa, vasa previa, and placenta accreta. Obstet Gynecol. 2011;126:654–668.
7.Cali G, Giambanco L, Puccio G, Forlani F. Morbidly adherent placenta: ultrasound diagnostic criteria and differentiation of accreta from percreta. Ultrasound Obstet Gynecol. 2013;41:406–412.
8.Rac MWF, Dashe JS, Wells CE, et al. Ultrasound predictors of abnormally invasive placenta by placental location and previous cesarean delivery. J Ultrasound Med. 2010;33:2029–2035.
9.Comstock CH, Love JJ Jr, Bronsteen RA, et al. Sonographic detection of placenta accreta in the second and third trimesters. Am J Obstet Gynecol. 2004;190:1135–1140.
10.D'Antonio F, Iacovella C, Bhide A. Prenatal identification of invasive placentation using ultrasound: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2012;42:509–517.
11.Tantbirojn P, Crum CP, Parast MM. Pathophysiology of placenta creta: role of decidua and extravillous trophoblast. Placenta. 2008;29:639–645.
12.Hecht JL, Baergen R, Ernst LM, et al. Classification and reporting guidelines for the pathology diagnosis of placenta accreta spectrum. Int J Gynaecol Obstet. 2002;155:37–44.
13.Khong TY. The pathology of placenta accreta, a worldwide epidemic. J Clin Pathol. 2008;61:1243–1246.
14.Tantbirojn P, Crum CP, Parast MM. Anatomic and histologic aspects of placenta accreta spectrum. Arch Pathol Lab Med. 2010;143:1004–1010.
15.Bailit JL, Grobman WA, Rice MM, et al. Morbidly adherent placenta treatments and outcomes. Obstet Gynecol. 2015;126:1114–1121.
16.Bowman ZS, Eller AG, Kennedy AM, et al. Accuracy of ultrasound for diagnosis of placenta accreta. Am J Obstet Gynecol. 2011;211:177.e1–177.e7.
17.Collins SL, Alemdar B, van Beekhuizen HJ, et al. Evidence-based guidelines for management of abnormally invasive placenta. Eur J Obstet Gynecol Reprod Biol. 2008;233:109–116.
18.Sentilhes L, Kayem G, Chandraharan E, et al. FIGO consensus guidelines on placenta accreta spectrum disorders: conservative management. Int J Gynaecol Obstet. 2009;146:291–308.